A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

Clinical trial NCT07212322 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07212322
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Idiopahic Inflammatory Myopathies Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Sjögren's Syndrome Antiphospholipid Syndrome Immune Thrombocytopenia Systemic Sclerosis

Start date: 2026-01-30
Primary completion: 2027-05-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.